{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:57:32Z","timestamp":1787849852762,"version":"build-2784847793"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1132003"],"award-info":[{"award-number":["U1132003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>MicroRNAs (miRNAs) have been shown to play a critical role in the development and progression of nasopharyngeal carcinoma (NPC). Although accumulating studies have been performed on the molecular mechanisms of NPC, the miRNA regulatory networks in cancer progression remain largely unknown. Laser capture microdissection (LCM) and deep sequencing are powerful tools that can help us to detect the integrated view of miRNA-target network.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Illumina Hiseq2000 deep sequencing was used to screen differentially expressed miRNAs in laser-microdessected biopsies between 12 NPC and 8 chronic nasopharyngitis patients. The result was validated by real-time PCR on 201 NPC and 25 chronic nasopharyngitis patients. The potential candidate target genes of the miRNAs were predicted using published target prediction softwares (RNAhybrid, TargetScan, Miranda, PITA), and the overlay part was analyzed in Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) biological process. The miRNA regulatory network analysis was performed using the Ingenuity Pathway Analysis (IPA) software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eight differentially expressed miRNAs were identified between NPC and chronic nasopharyngitis patients by deep sequencing. Further qRT-PCR assays confirmed 3 down-regulated miRNAs (miR-34c-5p, miR-375 and miR-449c-5p), 4 up-regulated miRNAs (miR-205-5p, miR-92a-3p, miR-193b-3p and miR-27a-5p). Additionally, the low level of miR-34c-5p (miR-34c) was significantly correlated with advanced TNM stage. GO and KEGG enrichment analyses showed that 914 target genes were involved in cell cycle, cytokine secretion and tumor immunology, and so on. IPA revealed that cancer was the top disease associated with those dysregulated miRNAs, and the genes regulated by miR-34c were in the center of miRNA-mRNA regulatory network, including TP53, CCND1, CDK6, MET and BCL2, and the PI3K\/AKT\/ mTOR signaling was regarded as a significant function pathway in this network.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study presents the current knowledge of miRNA regulatory network in NPC with combination of bioinformatics analysis and literature research. The hypothesis of miR-34c regulatory pathway may be beneficial in guiding further studies on the molecular mechanism of NPC tumorigenesis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13046-016-0292-4","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:21:20Z","timestamp":1453422080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing"],"prefix":"10.1186","volume":"35","author":[{"given":"Fan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"issue":"2","key":"292_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.anl.2011.02.012","volume":"39","author":"T Yoshizaki","year":"2012","unstructured":"Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S, Endo K. Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx. 2012;39(2):137\u201344.","journal-title":"Auris Nasus Larynx"},{"issue":"5","key":"292_CR2","first-page":"1187","volume":"34","author":"BE Henderson","year":"1974","unstructured":"Henderson BE. Nasopharyngeal carcinoma: present status of knowledge. Cancer Res. 1974;34(5):1187\u20138.","journal-title":"Cancer Res"},{"issue":"12","key":"292_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399407000312","volume":"9","author":"Q Tao","year":"2007","unstructured":"Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med. 2007;9(12):1\u201324.","journal-title":"Expert Rev Mol Med"},{"issue":"6","key":"292_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1044579X02000883","volume":"12","author":"KW Lo","year":"2002","unstructured":"Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12(6):451\u201362.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"292_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"key":"292_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","volume":"23","author":"N Bushati","year":"2007","unstructured":"Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007;23:175\u2013205.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"13","key":"292_CR7","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.4161\/cc.20898","volume":"11","author":"X Liu","year":"2012","unstructured":"Liu X, Lv XB, Wang XP, Sang Y, Xu S, Hu K, et al. MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle. 2012;11(13):2495\u2013506.","journal-title":"Cell Cycle"},{"issue":"2","key":"292_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.canlet.2013.10.023","volume":"344","author":"LJ Wang","year":"2014","unstructured":"Wang LJ, Chou YF, Chen PR, Su B, Hsu YC, Chang CH, et al. Differential miRNA expression in repeated recurrence of nasopharyngeal carcinoma. Cancer Lett. 2014;344(2):188\u201394.","journal-title":"Cancer Lett"},{"issue":"6","key":"292_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1470-2045(12)70102-X","volume":"13","author":"N Liu","year":"2012","unstructured":"Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol. 2012;13(6):633\u201341.","journal-title":"Lancet Oncol"},{"issue":"5","key":"292_CR10","first-page":"1353","volume":"25","author":"T Li","year":"2011","unstructured":"Li T, Chen JX, Fu XP, Yang S, Zhang Z, Chen K, et al. microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep. 2011;25(5):1353\u201363.","journal-title":"Oncol Rep"},{"issue":"15","key":"292_CR11","doi-asserted-by":"publisher","first-page":"5874","DOI":"10.1073\/pnas.0801130105","volume":"105","author":"S Sengupta","year":"2008","unstructured":"Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A. 2008;105(15):5874\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"292_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1755-8794-5-3","volume":"5","author":"Z Luo","year":"2012","unstructured":"Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, et al. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med Genomics. 2012;5:3. doi:10.1186\/1755-8794-5-3.","journal-title":"BMC Med Genomics"},{"issue":"5","key":"292_CR13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrg3198","volume":"13","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13(5):358\u201369.","journal-title":"Nat Rev Genet"},{"key":"292_CR14","doi-asserted-by":"publisher","unstructured":"Plieskatt JL, Rinaldi G, Feng Y, Levine PH, Easley S, Martinez E, et al. Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma. J Transl Med. 2014;12:3. doi:10.1186\/1479-5876-12-3.","DOI":"10.1186\/1479-5876-12-3"},{"key":"292_CR15","doi-asserted-by":"publisher","unstructured":"Chang YY, Kuo WH, Hung JH, Lee CY, Lee YH, Chang YC, et al. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing. Mol Cancer. 2015;14:36. doi:10.1186\/s12943-015-0301-9.","DOI":"10.1186\/s12943-015-0301-9"},{"issue":"9","key":"292_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/jcp.53.9.666","volume":"53","author":"F Fend","year":"2000","unstructured":"Fend F, Raffeld M. Laser capture microdissection in pathology. J Clin Pathol. 2000;53(9):666\u201372.","journal-title":"J Clin Pathol"},{"issue":"5342","key":"292_CR17","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.278.5342.1481","volume":"278","author":"RF Bonner","year":"1997","unstructured":"Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S, et al. Laser capture microdissection: molecular analysis of tissue. Science. 1997;278(5342):1481\u20133.","journal-title":"Science"},{"issue":"5289","key":"292_CR18","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1126\/science.274.5289.998","volume":"274","author":"MR Emmert-Buck","year":"1996","unstructured":"Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, et al. Laser capture microdissection. Science. 1996;274(5289):998\u20131001.","journal-title":"Science"},{"key":"292_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1471-2164-11-163","volume":"11","author":"S Wang","year":"2010","unstructured":"Wang S, Wang L, Zhu T, Gao X, Li J, Wu Y, et al. Improvement of tissue preparation for laser capture microdissection: application for cell type-specific miRNA expression profiling in colorectal tumors. BMC Genomics. 2010;11:163. doi:10.1186\/1471-2164-11-163.","journal-title":"BMC Genomics"},{"key":"292_CR20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"YHY Benjamini","year":"1995","unstructured":"Benjamini YHY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B. 1995;57:289\u2013300.","journal-title":"J Roy Statist Soc Ser B"},{"issue":"4","key":"292_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"Web Server issu","key":"292_CR22","doi-asserted-by":"publisher","first-page":"W451","DOI":"10.1093\/nar\/gkl243","volume":"34","author":"J Kruger","year":"2006","unstructured":"Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006;34(Web Server issue):W451\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"292_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","volume":"115","author":"BP Lewis","year":"2003","unstructured":"Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115(7):787\u201398.","journal-title":"Cell"},{"issue":"10","key":"292_CR24","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/ng2135","volume":"39","author":"M Kertesz","year":"2007","unstructured":"Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet. 2007;39(10):1278\u201384.","journal-title":"Nat Genet"},{"issue":"11","key":"292_CR25","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1371\/journal.pbio.0020363","volume":"2","author":"B John","year":"2004","unstructured":"John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. Plos Biol. 2004;2(11):e363.","journal-title":"Plos Biol"},{"issue":"Database issue","key":"292_CR26","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1093\/nar\/gkr988","volume":"40","author":"M Kanehisa","year":"2012","unstructured":"Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40(Database issue):D109\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"7006","key":"292_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nature02782","volume":"431","author":"NM Luscombe","year":"2004","unstructured":"Luscombe NM, Babu MM, Yu H, Snyder M, Teichmann SA, Gerstein M. Genomic analysis of regulatory network dynamics reveals large topological changes[J]. Nature. 2004;431(7006):308\u201312.","journal-title":"Nature"},{"key":"292_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3809-0","author":"Q Mao","year":"2015","unstructured":"Mao Q, Quan T, Luo B, Guo X, Liu L, Zheng Q. MiR-375 targets KLF4 and impacts the proliferation of colorectal carcinoma. Tumour Biol. 2015. doi:10.1007\/s13277-015-3809-0.","journal-title":"Tumour Biol"},{"issue":"1","key":"292_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.gene.2015.04.065","volume":"567","author":"M Kara","year":"2015","unstructured":"Kara M, Yumrutas O, Ozcan O, Celik OI, Bozgeyik E, Bozgeyik I, et al. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene. 2015;567(1):81\u20136.","journal-title":"Gene"},{"key":"292_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.lfs.2015.06.020","volume":"137","author":"Z Wu","year":"2015","unstructured":"Wu Z, Wang H, Fang S, Xu C. MiR-449c inhibits gastric carcinoma growth. Life Sci. 2015;137:14\u20139.","journal-title":"Life Sci"},{"issue":"2","key":"292_CR31","first-page":"1175","volume":"8","author":"J Bai","year":"2015","unstructured":"Bai J, Zhu X, Ma J, Wang W. miR-205 regulates A549 cells proliferation by targeting PTEN. Int J Clin Exp Pathol. 2015;8(2):1175\u201383.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"292_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbrc.2015.01.066","volume":"458","author":"C Zhou","year":"2015","unstructured":"Zhou C, Shen L, Mao L, Wang B, Li Y, Yu H. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7. Biochem Biophys Res Commun. 2015;458(1):63\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"292_CR33","first-page":"2259","volume":"8","author":"H Peng","year":"2015","unstructured":"Peng H, Wang X, Zhang P, Sun T, Ren X, Xia Z. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma. Int J Clin Exp Pathol. 2015;8(2):2259\u201366.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"292_CR34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jnr.23339","volume":"92","author":"Q Zhong","year":"2014","unstructured":"Zhong Q, Wang T, Lu P, Zhang R, Zou J, Yuan S. miR-193b promotes cell proliferation by targeting Smad3 in human glioma. J Neurosci Res. 2014;92(5):619\u201326.","journal-title":"J Neurosci Res"},{"issue":"24","key":"292_CR35","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.1158\/1078-0432.CCR-11-2102","volume":"17","author":"AB Hui","year":"2011","unstructured":"Hui AB, Bruce JP, Alajez NM, Shi W, Yue S, Perez-Ordonez B, et al. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res. 2011;17(24):7539\u201350.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"292_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.4161\/cc.11.4.19228","volume":"11","author":"C Qu","year":"2012","unstructured":"Qu C, Liang Z, Huang J, Zhao R, Su C, Wang S, et al. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle. 2012;11(4):785\u201396.","journal-title":"Cell Cycle"},{"key":"292_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.582","author":"YQ Li","year":"2015","unstructured":"Li YQ, Ren XY, He QM, Xu YF, Tang XR, Sun Y, et al. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET. Cell Death Dis. 2015. doi:10.1038\/cddis.2014.582.","journal-title":"Cell Death Dis"},{"issue":"2","key":"292_CR38","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/0008-5472.CAN-11-1977","volume":"72","author":"A Heinemann","year":"2012","unstructured":"Heinemann A, Zhao F, Pechlivanis S, Eberle J, Steinle A, Diederichs S, et al. Tumor suppressive microRNAs miR-34a\/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res. 2012;72(2):460\u201371.","journal-title":"Cancer Res"},{"issue":"7","key":"292_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrd4506","volume":"14","author":"RW Childs","year":"2015","unstructured":"Childs RW, Carlsten M. Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens. Nat Rev Drug Discov. 2015;14(7):487\u201398.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"292_CR40","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.3892\/mmr.2015.3863","volume":"12","author":"JJLS Chen","year":"2015","unstructured":"Chen JJLS. Has-miR-125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53-dependent manner by targeting p53 mRNA. Mol Med Rep. 2015;12(3):3569\u201374.","journal-title":"Mol Med Rep"},{"issue":"3","key":"292_CR41","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s13277-013-0736-9","volume":"34","author":"L Li","year":"2013","unstructured":"Li L, Wu J, Sima X, Bai P, Deng W, Deng X, et al. Interactions of miR-34b\/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour Biol. 2013;34(3):1919\u201323.","journal-title":"Tumour Biol"},{"issue":"2","key":"292_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.biocel.2011.11.007","volume":"44","author":"Z Li","year":"2012","unstructured":"Li Z, Chen X, Li L, Liu S, Yang L, Ma X, et al. EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma. Int J Biochem Cell Biol. 2012;44(2):275\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"292_CR43","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.4238\/2014.February.14.6","volume":"13","author":"SM Fu","year":"2014","unstructured":"Fu SM, Xu MX, Lin SM, Liang Z, Cai JH. Association of cyclin D1 and survivin expression with sensitivity to radiotherapy in patients with nasopharyngeal carcinoma. Genet Mol Res. 2014;13(2):3502\u20139.","journal-title":"Genet Mol Res"},{"key":"292_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1756-9966-32-90","volume":"32","author":"Y Xu","year":"2013","unstructured":"Xu Y, Shi Y, Yuan Q, Liu X, Yan B, Chen L, et al. Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J Exp Clin Cancer Res. 2013;32:90. doi:10.1186\/1756-9966-32-90.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"292_CR45","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/carcin\/bgs346","volume":"34","author":"LY Zhang","year":"2013","unstructured":"Zhang LY, Ho-Fun LV, Wong AM, Kwong DL, Zhu YH, Dong SS, et al. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis. 2013;34(2):454\u201363.","journal-title":"Carcinogenesis"},{"issue":"1","key":"292_CR46","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1158\/0008-5472.CAN-10-1850","volume":"71","author":"J Lu","year":"2011","unstructured":"Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res. 2011;71(1):225\u201333.","journal-title":"Cancer Res"},{"issue":"5","key":"292_CR47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s13277-010-0047-3","volume":"31","author":"A Fendri","year":"2010","unstructured":"Fendri A, Kontos CK, Khabir A, Mokdad-Gargouri R, Ardavanis A, Scorilas A. Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor. Tumour Biol. 2010;31(5):391\u20139.","journal-title":"Tumour Biol"},{"issue":"6","key":"292_CR48","first-page":"3478","volume":"7","author":"Y Li","year":"2014","unstructured":"Li Y, Yan L, Zhang W, Wang H, Chen W, Hu N, et al. miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression. Int J Clin Exp Pathol. 2014;7(6):3478\u201387.","journal-title":"Int J Clin Exp Pathol"},{"key":"292_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.376","volume":"4","author":"Y Zhen","year":"2013","unstructured":"Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S, et al. Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma. Cell Death Dis. 2013;4, e872. doi:10.1038\/cddis.2013.376.","journal-title":"Cell Death Dis"},{"key":"292_CR50","doi-asserted-by":"publisher","unstructured":"Xiang Q, Zhen Z, Deng DY, Wang J, Chen Y, Li J, et al. Tivantinib induces G2\/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:118. doi:10.1186\/s13046-015-0238-2.","DOI":"10.1186\/s13046-015-0238-2"},{"key":"292_CR51","doi-asserted-by":"publisher","unstructured":"Liu J, Xue H, Zhang J, Suo T, Xiang Y, Zhang W, et al. MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression. J Exp Clin Cancer Res. 2015;34:35. doi:10.1186\/s13046-015-0154-5.","DOI":"10.1186\/s13046-015-0154-5"},{"key":"292_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.119","volume":"5","author":"BS Lee","year":"2014","unstructured":"Lee BS, Kang S, Kim KA, Song YJ, Cheong KH, Cha HY, et al. Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression. Cell Death Dis. 2014;5, e1159. doi:10.1038\/cddis.2014.119.","journal-title":"Cell Death Dis"},{"issue":"23\u201324","key":"292_CR53","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1016\/j.febslet.2008.09.004","volume":"582","author":"HY Zhou","year":"2008","unstructured":"Zhou HY, Wan KF, Ip CK, Wong CK, Mak NK, Lo KW, et al. Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK. Febs Lett. 2008;582(23\u201324):3415\u201322.","journal-title":"Febs Lett"},{"issue":"1","key":"292_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbrc.2014.04.147","volume":"449","author":"T Liu","year":"2014","unstructured":"Liu T, Li Q, Sun Q, Zhang Y, Yang H, Wang R, et al. MET inhibitor PHA-665752 suppresses the hepatocyte growth factor-induced cell proliferation and radioresistance in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2014;449(1):49\u201354.","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"292_CR55","doi-asserted-by":"publisher","first-page":"13309","DOI":"10.18632\/oncotarget.3751","volume":"6","author":"Y Li","year":"2015","unstructured":"Li Y, Li W, He Q, Xu Y, Ren X, Tang X, et al. Prognostic value of MET protein overexpression and gene amplification in locoregionally advanced nasopharyngeal carcinoma. Oncotarget. 2015;6(15):13309\u201319.","journal-title":"Oncotarget"}],"updated-by":[{"DOI":"10.1186\/s13046-022-02311-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000}}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-016-0292-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-016-0292-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-016-0292-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-016-0292-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T22:35:42Z","timestamp":1718318142000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-016-0292-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1186\/s13046-016-0292-4","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13046-022-02311-7","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]},"assertion":[{"value":"2 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13046-022-02311-7","URL":"https:\/\/doi.org\/10.1186\/s13046-022-02311-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"17"}}